For: | Li F, Li H, Luo R, Pei JB, Yu XY. Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation. World J Clin Cases 2023; 11(26): 6066-6072 [PMID: 37731575 DOI: 10.12998/wjcc.v11.i26.6066] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v11/i26/6066.htm |
Number | Citing Articles |
1 |
Christos Kourek, Alexandros Briasoulis, Grigorios Giamouzis, John Skoularigis, Andrew Xanthopoulos. Lyophilized recombinant human brain natriuretic peptide: A promising therapy in patients with chronic heart failure. World Journal of Clinical Cases 2023; 11(36): 8603-8605 doi: 10.12998/wjcc.v11.i36.8603
Abstract(188) |
Core Tip(131) |
Full Article(HTML)(799)
|
Full Article with Cover (PDF)-878K(16)
|
Full Article (Word)-231K(15)
|
Audio-1095K(2)
|
Peer-Review Report-212K(15)
|
Answering Reviewers-119K(14)
|
Full Article (PDF)-514K(59)
|
Full Article (XML)-21K(17)
|
Times Cited (1)
|
Total Visits (1689)
|
Open
|
2 |
启俊 刘. Application Progress of Recombinant Human Brain Natriuretic Peptide in Clinical Practice. Advances in Clinical Medicine 2024; 14(04): 2573 doi: 10.12677/acm.2024.1441330
|